Author:
Castenmiller S.M.,de Groot R.,Guislain A.,Monkhorst K.,Hartemink K.J.,Veenhof A.A.F.A.,Smit E.F.,Haanen J.B.A.G.,Wolkers M.C.
Funder
Sanquin Blood Supply Foundation
Subject
Oncology,Immunology and Allergy
Reference62 articles.
1. Cancer statistics, 2020;Siegel;CA Cancer J Clin,2020
2. Treatment of non-small cell lung cancer with EGFR-mutations;Yoneda;J UOEH,2019
3. Making the first move in EGFR-driven or ALK-driven NSCLC: first-generation or next-generation TKI?;Recondo;Nat Rev Clin Oncol,2018
4. Pembrolizumab for all PD-L1-positive NSCLC;Smit;Lancet,2019
5. Anti-PD-1/PD-L1 therapy for non-small-cell lung cancer: toward personalized medicine and combination strategies;Sui;J Immunol Res,2018
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献